6090 Human Metabolome Technologies, Inc. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

6090

TSE Standard

Human Metabolome Technologies, Inc.

651

JPY

(+1.09%)

Dec 5, 2:15 pm JST

4.20

USD

Dec 5, 12:15 am EST

Result

PTS

outside of trading hours

659

Dec 5, 1:07 pm JST

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun, 2022	1,223	191	253	267	45.4	0	Aug 10, 2022	J-GAAP
Jun, 2023	1,299	210	232	285	48.4	10	Aug 10, 2023	J-GAAP
Jun, 2024	1,345	220	241	243	41.1	15	Aug 9, 2024	J-GAAP
Jun, 2025	1,455	249	240	256	43.7	15	Aug 8, 2025	J-GAAP
Jun, 2026 Guidance	1,600	300	300	260	46.2	18	Aug 8, 2025	J-GAAP
YoY	+10.0%	+20.5%	+25.0%	+1.6%	+5.8%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Jun, 2021	Aug 14, 2020	1,200	20	35	10	0	J-GAAP
Results	Aug 13, 2021	1,124	39	59	58	0	J-GAAP
Jun, 2022	Aug 13, 2021	Available in future release
	Feb 14, 2022
	May 13, 2022
Results	Aug 10, 2022
Jun, 2023	Aug 10, 2022
	May 12, 2023
Results	Aug 10, 2023
Jun, 2024	Aug 10, 2023
Results	Aug 9, 2024
Jun, 2025	Aug 9, 2024
Results	Aug 8, 2025
Jun, 2026	Aug 8, 2025	1,600	300	300	260	18	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2009	245	－	Available in future release
Mar, 2010	380	+55.1
Mar, 2011	568	+49.5
Mar, 2012	521	-8.3
Mar, 2013	496	-4.8
Mar, 2014	610	+23.0
Mar, 2015	686	+12.5
Mar, 2016	780	+13.7
Mar, 2017	914	+17.2
Mar, 2018	938	+2.6
Jun, 2019 Changed	989	－
Jun, 2020	1,118	+13.0
Jun, 2021	1,124	+0.5
Jun, 2022	1,223	+8.8
Jun, 2023	1,299	+6.2
Jun, 2024	1,345	+3.5
Jun, 2025	1,455	+8.2
Jun, 2026 Guidance	1,600	+10.0	300	+20.5	300	+25.0	46.2	+5.7

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Jun, 2024	1,345	220	16.4	13.54	9.93	0.55	41.1
Jun, 2025	1,455	249	17.1	13.54	10.29	0.58	43.7
Jun, 2026 Guidance	1,600	300	18.8	15.42	12.99	0.80	46.2

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,455	249	253	285	5,935.8
Fiscal Year	Jun, 2025	Jun, 2025	Jun, 2022	Jun, 2023	Mar, 2011

First Half

Result

Guidance History

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2022	610	84	86	74	12.6	0	Feb 14, 2023	J-GAAP
Jul - Dec, 2023	632	71	70	71	12.0	0	Feb 14, 2024	J-GAAP
Jul - Dec, 2024	684	104	94	93	15.8	0	Feb 13, 2025	J-GAAP
Jul - Dec, 2025 Guidance	ー	ー	ー	ー	－	0	Aug 8, 2025	J-GAAP
YoY	－	－	－	－	－

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2022	Aug 10, 2022	ー	ー	ー	ー	0	J-GAAP
- - - - Results	Feb 14, 2023	610	84	86	74	0	J-GAAP
Dec, 2023	Aug 10, 2023	Available in future release
Results	Feb 14, 2024
Dec, 2024	Aug 9, 2024
Results	Feb 13, 2025
Dec, 2025	Aug 8, 2025	ー	ー	ー	ー	0	J-GAAP

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Jun, 2023	210	168	284	-116	-13	1,656	72.28	J-GAAP
Jun, 2024	220	204	236	-32	-73	1,788	68.69	J-GAAP
Jun, 2025	249	176	373	-197	-369	1,594	67.14	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 1st Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jul - Sep, 2023	235	-30	-30	-38	-6.5	ー	Nov 10, 2023	J-GAAP
Jul - Sep, 2024	274	-5	-14	-35	-6.0	ー	Nov 13, 2024	J-GAAP
Jul - Sep, 2025	192	-91	-90	-97	-17.1	ー	Nov 12, 2025	J-GAAP
YoY	-29.9%	-1,720.0%	-542.9%	-177.1%	-185.5%

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	397	101	100	109	18.5	25.4	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	483	180	181	157	26.6	37.3	May 15, 2024	J-GAAP
Apr - Jun, 2024	230	-31	-10	15	2.5	-13.5	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	274	-5	-14	-35	-6.0	-1.8	Nov 13, 2024	J-GAAP
Oct - Dec, 2024	410	109	108	128	21.7	26.6	Feb 13, 2025	J-GAAP
Jan - Mar, 2025	582	249	248	211	35.8	42.8	May 14, 2025	J-GAAP
Apr - Jun, 2025	189	-104	-102	-48	-8.2	-55.0	Aug 8, 2025	J-GAAP
Jul - Sep, 2025	192	-91	-90	-97	-17.1	-47.4	Nov 12, 2025	J-GAAP
YoY	-29.9%	-1,720.0%	-542.9%	-177.1%	-185.5%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	292	+14.1	Available in future release
Jan - Mar, 2021	389	-27.8
Apr - Jun, 2021	198	+58.4
Jul - Sep, 2021	173	-29.4
Oct - Dec, 2021	360	+23.3
Jan - Mar, 2022	477	+22.6
Apr - Jun, 2022	213	+7.6
Jul - Sep, 2022	262	+51.4
Oct - Dec, 2022	348	-3.3
Jan - Mar, 2023	465	-2.5
Apr - Jun, 2023	224	+5.2
Jul - Sep, 2023	235	-10.3
Oct - Dec, 2023	397	+14.1
Jan - Mar, 2024	483	+3.9
Apr - Jun, 2024	230	+2.7
Jul - Sep, 2024	274	+16.6
Oct - Dec, 2024	410	+3.3
Jan - Mar, 2025	582	+20.5
Apr - Jun, 2025	189	-17.8
Jul - Sep, 2025	192	-29.9	-91	-1,720.0	-90	-542.9	-17.1	-185.0

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	582	251	251	211	39.5
Fiscal Year	Mar, 2025	Mar, 2020	Mar, 2020	Mar, 2025	Mar, 2014

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Jun, 2023	287.37	74.1	2,291	1,697	233	0.13	Aug 10, 2023	J-GAAP
Jun, 2024	320.00	72.7	2,603	1,892	417	0.12	Aug 9, 2024	J-GAAP
Jun, 2025	332.14	79.6	2,374	1,890	585	0.06	Aug 8, 2025	J-GAAP
Jul - Sep, 2025	ー	84.2	2,002	1,686	402	0.06	Nov 12, 2025	J-GAAP

Human Metabolome Technologies, Inc.(6090) Financial Results